Benzthiazide
CAS No. 91-33-8
Benzthiazide( Benzthiazide | Benzothiazide | Dihydrex | Aquatag | Diucen | Exna | Edemax | Foven | Dytide )
Catalog No. M16562 CAS No. 91-33-8
Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 35 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenzthiazide
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics).
-
DescriptionBenzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue. (In Vitro):Benzthiazide (0.4, 2, 10 μM) suppresses proliferation of cancer cell under hypoxic conditions in a dose-dependent mannerBenzthiazide is an inhibitor of carbonic anhydrase 9 (CA9), with Kis of 8.0, 8.8 and 10 nM for CA9, CA2 and CA1, respectively.(In Vivo):Benzthiazide (1, 1.5 mg/100 g BW) causes a marked decrease in urinary calcium excretion and the dissociation of calcium and sodium excretion in hyperprolactinemic rats.
-
In Vitro——
-
In Vivo——
-
SynonymsBenzthiazide | Benzothiazide | Dihydrex | Aquatag | Diucen | Exna | Edemax | Foven | Dytide
-
PathwayMembrane Transporter/Ion Channel
-
TargetCarbonic Anhydrase
-
RecptorCarbonic anhydrase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number91-33-8
-
Formula Weight431.94
-
Molecular FormulaC15H14ClN3O4S3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=S(N=C1CSCC2=CC=CC=C2)(C3=CC(S(=O)(N)=O)=C(Cl)C=C3N1)=O
-
Chemical NameBenzthazide; 3-[(benzylsulfanyl)methyl]-6-chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Temperini C, et al. Bioorg Med Chem. 2009 Feb 1;17(3):1214-2
molnova catalog
related products
-
hCAI/II-IN-6
hCAI/II-IN-6 is a selective and orally active inhibitor of human carbonic anhydrase (CA). hCAI/II-IN-6 inhibited hCA I, hCA II, hCA VII, and hCA XII with Ki values of 220, 4.9, 6.5, and >50,000 nM.
-
Topiramate
Topiramate (brand name Topamax) is an anticonvulsant drug produced by Ortho-McNeil Neurologics.
-
hCAIX-IN-5
hCAIX-IN-5 was a selective hCAIX inhibitor, inhibiting hCAI, hCAII, hCAIV, and hCAIX with Ki values of >10000, >10000, 130.7, and 829.1 nM, respectively.
Cart
sales@molnova.com